Neurogene Inc. (NGNE) Debt to Equity Ratio
Neurogene Inc. (NGNE) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2018-12-31 | 0.00 |
| 2019-12-31 | 0.01 |
| 2020-12-31 | 0.06 |
| 2021-12-31 | 0.09 |
| 2022-12-31 | 0.05 |
| 2023-12-31 | 0.08 |
| 2024-12-31 | 0.04 |
| 2025-12-31 | 0.04 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Neurogene Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("NGNE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NGNE | $38.63 | +1.68% | 0.35M |
| 3 | ||||
| 4 | ||||
| 5 |